-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Hematology Inclusion Pathway (HIP) Oral Presentations - Classical Hematology

Program: Special-Interest Sessions
Hematology Disease Topics & Pathways:
Diversity, Equity, and Inclusion (DEI)
Saturday, December 7, 2024: 6:00 PM-9:00 PM
Marina Ballroom E (Marriott Marquis San Diego Marina)
Moderators:
Cecelia Calhoun, MD, MBA, MPH, Yale School of Medicine and Dailia B. Francis, MD, PhD, Aflac Cancer & Blood Disorders Center at Children's Healthcare of Atlanta and Imo J. Akpan, MD, Columbia University
Disclosures:
Akpan: Pharmacosmos Therapeutics Inc: Consultancy, Honoraria, Speakers Bureau.
The Hematology Inclusion Pathway Presentations and Reception (previously known as Promoting Minorities in Hematology); ASH invites all interested meeting attendees to this event, which will showcase the research of our Hematology Inclusion Pathway awardees. This initiative is a comprehensive 13-year longitudinal career pathway of awards that strives to ensure that hematology reflects and serves the diverse world we live in. The highlight of the session will be oral scientific presentations from program participants. 
Investigating the Role of Long Interspersed Element-1 (LINE-1) in Age-Related Clonal Hematopoiesis of Indeterminate Potential (CHIP) Driven By JAK2 V617F Mutation

Valeria Brown

The Warren Alpert Medical School of Brown University, Providence, RI
A Study of Postpartum Hemorrhage and a Cryoprecipitate Intervention at Hospital Central De Maputo

Esther Chioma Emenalom

Hemophilia and Thrombosis Treatment Center, University of California, San Diego, San Diego, CA
Incidence of Thrombotic and Bleeding Complications in Patients with Cancer Undergoing Lower Extremity Arthroplasty, an Administrative Database Study

Maria Fernanda Albuja Altamirano, MD

Internal Medicine, Lincoln General Hospital, New York, NY
Monocyte Distribution Width As a Marker of Red Cell Alloimmunization

Ashley Crosby, MD

Department of Pathology, Atrium Health Wake Forest Baptist Medical Center, Winston Salem, NC
Evaluating the Role of Voxelotor and Percent Modified Hemoglobin (Hemoglobin X) on Laboratory and Clinical Responses in Patients with Sickle Cell Disease

Ayotola A. Fatola, MD

Johns Hopkins University School of Medicine, Baltimore, MD
Can Emergency Hematopoiesis Due to Sepsis Lead to Clonal Hematopoiesis? Implications for Understanding the Pathogenesis of Clonal Evolution

Olisaemeka Ogbue, MBBS

Fairview Hospital, Cleveland Clinic Foundation, Rocky River, OH
Heterozygous DDX41 Mutations Promote Age-Dependent Hematopoietic Stem and Progenitor Dysfunction

Maria Feliz Norberto, MS

Department of Developmental and Molecular Biology, Albert Einstein College of Medicine, Bronx, NY
Role of Platelet Factor 4 in the Prothrombotic Nature of Antiphospholipid Syndrome

Conroy O Field, MS

The University of Pennsylvania School of Medicine, Philadelphia, PA
Methionine Sulfoxide and Other Metabolites from Bronchoalveolar Lavage Are Associated with Neutrophil-Dominated Lung Disease in Early Cystic Fibrosis

Sarah Mansour

Emory University, Atlanta, GA
The Role of Red Blood Cell Vascular Adhesion Biomarkers in Understanding Sickle Cell Disease-Associated Chronic Pain

Olufunke Y. Martin, MD

Children's National Hospital, Washington DC, DC
Interrogating TCF15 Function in Native Hematopoiesis Using TCF15 Overexpression and Conditional Knock out Mouse Models

Walatta-Tseyon Mesquitta, BSc, DPhil

Boston Children's Hospital, Boston, MA
See more of: Special-Interest Sessions
<< Previous Session | Next Session >>